ALS-FUS cases are marked by aberrant accumulation of cytoplasmic FUS inclusions in neurons and glia, some of which are reported to be immunoreactive for ubiquitin–proteasome system components (such as ubiquitin and p62), and are often accompanied by reduced nuclear FUS. Here, FUS is linked to amyotrophic lateral sclerosis.